Todd McDevitt, Ph.D,  Director & Co-Founder


Todd McDevitt, Ph.D. is a Senior Investigator at the Gladstone Institutes and a Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco. Previously, Dr. McDevitt was the Carol Ann and David D. Flanagan Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, founding Director of the Stem Cell Engineering Center at Georgia Tech, and a Faculty Member and former Petit Faculty Fellow in the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech. Dr. McDevitt has 17 years of experience in biomaterials and tissue engineering research and for the past 13 years has focused primarily on stem cell biology and engineering. The objective of Dr. McDevitt’s research program is to develop enabling technologies for the directed differentiation of stem cells for regenerative medicine, models of development and disease, and diagnostic applications. Much of the research in the McDevitt laboratory focuses on the application of microscale technologies to engineer stem cell fate and provide scalable and robust approaches for stem cell bioprocessing.


Dr. McDevitt graduated cum laude with a Bachelor of Science in Engineering (B.S.E.) from Duke University in 1997 double majoring in Biomedical and Electrical Engineering, received his Ph.D. in Bioengineering from the University of Washington in 2001, and conducted post-doctoral research in the Department of Pathology at the University of Washington from 2002-04. He spent 10 years at Georgia Tech (2004-14) before moving to the Gladstone Institutes after receiving a California Institute for Regenerative Medicine (CIRM) Research Leadership Award.